SummaryHypertonic saline has been in clinical use for many decades. Its osmotic and volumeexpanding properties make it theoretically useful for a number of indications in critical care. This literature review evaluates the use of hypertonic saline in critical care. The putative mechanism of action is presented, followed by a narrative review of its clinical usefulness in critical care. The review was conducted using the Scottish Intercollegiate Guidelines Network method for the review of cohort studies, randomised-controlled trials and meta-analyses. The review focuses specifically on blood pressure restoration and outcome benefit in both haemorrhagic and non-haemorrhagic shock, and the management of raised intracranial pressure. Issues of clinical improvement and outcome benefit are addressed. Hypertonic saline solutions are effective for blood pressure restoration in haemorrhagic, but not other, types of shock. There is no survival benefit with the use of hypertonic saline solutions in shock. Hypertonic saline solutions are effective at reducing intracranial pressure in conditions causing acute intracranial hypertension. There is no survival or outcome benefit with the use of hypertonic saline solutions for raised intracranial pressure. Recommendations for clinical use and future directions of clinical research are presented. . Experimental work on compartmental fluid shifts in animals [3] confirmed hypertonic saline produced haemodynamic changes and its use in many different clinical settings has followed. In 1980, de Fillipe reported almost miraculous recovery from near-fatal haemorrhagic shock in 11 patients [4]. This was thought to be due to osmotic fluid shifts, and led to a resurgence of interest in the clinical use of hypertonic saline. Subsequent studies have demonstrated that the mechanism of action of hypertonic solutions is due to more than just changes in serum osmolality [5,6]. Despite further trials, clinical use of hypertonic saline solutions remains inconsistent and few clinical guidelines exist. Various concentrations of hypertonic saline and combinations with colloids have been used in clinical studies. Concerns persist about the safety of hypertonic solutions in critically ill patients as acute hyperosmolar states have been reported to cause harm. Currently the primary clinical areas of use are the management of intracranial hypertension and shock.The purpose of this review is to focus on clinically relevant aspects of the use of intravenous hypertonic saline. Specifically, three areas will be addressed: 1 Does intravenous hypertonic saline increase blood pressure and survival in hypotensive states? 2 Does intravenous hypertonic saline reduce intracranial pressure and improve outcome for patients with intracranial hypertension? Anaesthesia, 2009Anaesthesia, , 64, pages 990-1003Anaesthesia, doi:10.1111Anaesthesia, /j.1365Anaesthesia, -2044Anaesthesia, .2009.05986. x ...........................................................................................................................